SKI Market

A+| A| A-|

Indian Indices

Sensex

77,269.40 355.90
( 0.46%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

72.02

7958.22

EPS(TTM)

Face Value()

Div & Yield %

5.65

0.12

Back

galada power & telecommunication ltd

Jindal Saw consolidated net profit declines 49.06% in the December 2025 quarter

Jan 16,2026

Net profit of Jindal Saw declined 49.06% to Rs 257.99 crore in the quarter ended December 2025 as against Rs 506.42 crore during the previous quarter ended December 2024. Sales declined 6.22% to Rs 4943.41 crore in the quarter ended December 2025 as against Rs 5271.30 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4943.41	5271.30	-6
OPM %	12.39	17.82	-
PBDT	502.10	795.91	-37
PBT	347.19	645.26	-46
NP	257.99	506.42	-49

77,269.40 355.90 ( 0.46%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)